Socinski MA - Search Results

1

Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.

Wang K, Eblan MJ, Deal AM, Lipner M, Zagar TM, Wang Y, Mavroidis P, Lee CB, Jensen BC, Rosenman JG, Socinski MA, Stinchcombe TE, Marks LB. Wang K, et al. Among authors: socinski ma. J Clin Oncol. 2017 May 1;35(13):1387-1394. doi: 10.1200/JCO.2016.70.0229. Epub 2017 Jan 23. J Clin Oncol. 2017. PMID: 28113017 Free PMC article. Clinical Trial.

2

Neoadjuvant treatment of stage IIIA non-small cell lung cancer. Long-term results.

Elias AD, Skarin AT, Gonin R, Oliynyk P, Stomper PC, O'Hara C, Socinski MA, Sheldon T, Maggs P, Frei E 3rd. Elias AD, et al. Among authors: socinski ma. Am J Clin Oncol. 1994 Feb;17(1):26-36. doi: 10.1097/00000421-199402000-00007. Am J Clin Oncol. 1994. PMID: 8311004 Clinical Trial.

3

Chemotherapy helps patients with advanced non-small cell carcinoma of the lung.

Socinski MA, Detterbeck FC, Rivera MP, Egan TM, Halle J, Rosenman J. Socinski MA, et al. N C Med J. 1996 Sep-Oct;57(5):281-6. N C Med J. 1996. PMID: 8854691 Review. No abstract available.

4

High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer.

Socinski MA, Shea TC. Socinski MA, et al. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-45-S12-51. Semin Oncol. 1997. PMID: 9331121 Review.

5

Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial.

Socinski MA, Clark JA, Halle J, Steagall A, Kaluzny B, Rosenman JG. Socinski MA, et al. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-117-S12-122. Semin Oncol. 1997. PMID: 9331135 Clinical Trial.

6

Second-line chemotherapy with 96-hour infusional paclitaxel in refractory non-small cell lung cancer: report of a phase II trial.

Socinski MA, Steagall A, Gillenwater H. Socinski MA, et al. Cancer Invest. 1999;17(3):181-8. doi: 10.3109/07357909909021419. Cancer Invest. 1999. PMID: 10099656 Clinical Trial.

7

Combined-modality therapy in the nonsurgical management of unresectable stage III non-small cell lung cancer.

Hensing TA, Socinski MA. Hensing TA, et al. Among authors: socinski ma. Curr Opin Pulm Med. 1999 Jul;5(4):194-200. doi: 10.1097/00063198-199907000-00003. Curr Opin Pulm Med. 1999. PMID: 10407686 Review.

8

Single-agent paclitaxel in the treatment of advanced non-small cell lung cancer.

Socinski MA. Socinski MA. Oncologist. 1999;4(5):408-16. Oncologist. 1999. PMID: 10551557 Free article.

9

The current status of adjuvant chemotherapy for resected non-small cell lung cancer.

Socinski MA. Socinski MA. Semin Oncol. 1999 Oct;26(5 Suppl 15):27-33. Semin Oncol. 1999. PMID: 10566608 Review.

10

Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer.

Socinski MA, Langer CJ. Socinski MA, et al. Semin Oncol. 1999 Oct;26(5 Suppl 16):51-61; discussion 71-2. Semin Oncol. 1999. PMID: 10585009 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

344 results

Search Page

Filters